Estimating the opportunity–cost-based cost–effectiveness threshold: a peek behind the podcast

Written by The Evidence Base
Decision science Health technology assessment Interviews ISPOR Methodology Stakeholder engagement

At the International Society for Pharmacoeconomics and Outcomes Research's 2019 European meeting (2–6 November; Copenhagen, Denmark), we filmed an exclusive panel discussion on opportunity–cost-based cost–effectiveness, between ISPOR President Nancy Devlin (University of Melbourne, Australia), James Lomas (University of York, UK), Danny Palnoch (NHS England, UK) and Martin Henriksson (Linkoping University, Sweden). Over the course of ISPOR Europe (2–6 November 2019; Copenhagen, Denmark), The Evidence Base® brought you daily video updates, news and plenary round-ups –“ check out our conference coverage here>> We also had the exciting opportunity to reconvene ISPOR President Nancy Devlin (University of Melbourne, Australia), James Lomas (University of York,...

To view this content, please register now for access

It's completely free